NDC product
Standardized Mite Dermatophagoides farinae
NDC 22840-0038 · Greer Laboratories, Inc.
Key facts
| Product NDC | 22840-0038 |
|---|---|
| Proprietary name | Standardized Mite Dermatophagoides farinae |
| Nonproprietary name | Dermatophagoides farinae |
| Substances | DERMATOPHAGOIDES FARINAE |
| Dosage form | CONCENTRATE |
| Route | INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS |
| Labeler | Greer Laboratories, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Application number | BLA101834 |
| Pharmacologic classes | Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE] and 2 more |
| Marketing start | Feb 3, 2010 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: